CMS Open Payments · Program Year 2024
Nielsen BioSciences, Inc.
Nielsen BioSciences, Inc. reported $3,313,138.65 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 24 transactions.
- $3.3M Top quartile payer
- All-tracks total
- 24 Below-median volume
- Transactions
- 0 —
- Recipients
- #341
- of 1,925 companies
Nielsen BioSciences, Inc. reported $3,313,138.65 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #341 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.
Nielsen BioSciences, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
26/100
Total payments
F
41/100
Transaction volume
F
10/100
Physician reach and Payment type diversity not applicable for Nielsen BioSciences, Inc. - no recorded activity on that dimension; its weight was redistributed to the applicable dimensions above.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer nielsen-biosciences-inc Nielsen BioSciences, Inc.
$3.3M · #341/1,925 · 0.0% industry · PY2024
- TOT $3.3M
- RANK #341
- SHARE 0.0%
- TXN 24
- RCP 0
- CAT 0
- GEN n/a
- PY 2024
Volume peers
Nearest volume peer: Paratek Pharmaceuticals, Inc. ($3.3M)
Nielsen BioSciences, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Nielsen BioSciences, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Nielsen BioSciences, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Nielsen BioSciences, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Biotissue Holdings Inc.
LEO Pharma Inc.
Merit Medical Systems Inc
Oyster Point Pharma, Inc.
Elekta, Inc.
Put this to use
Nielsen BioSciences, Inc. ranks #341 of 1,925 by all-tracks total payments.
- See where Nielsen BioSciences, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare payment categories across every manufacturer. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.